The reduction in reauthorization requirements by Optum Rx, a unit of UnitedHealth, is likely to improve patient access to medications, which can enhance customer satisfaction and potentially lead to increased usage of their services. This move is seen as a positive step in corporate responsibility and could positively impact UnitedHealth's stock price in the short term.